This reference contains the names of substances and descriptions of the chemical formulas (including the structural formula and the skeletal formula).
Selected category:
Antiviral drugs
Total count of records found: 92.
Showed records: 12.
Molecular formula:
C38H53N5O7S2
CAS# 1000287-05-7
Names
English:
(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[({2-[(1-cyclopentyl-4-piperidinyl)amino]-1,3-benzothiazol-6-yl}sulfonyl)(isobutyl)amino]-3-hydroxy-1-phenyl-2-butanyl}carbamate (IUPAC) ; ASC-09 ; Carbamic acid, N-[(1S,2R)-3-[[[2-[(1-cyclopentyl-4-piperidinyl)amino]-6-benzothiazolyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl e ster (CAS) ; TMC-310911 [Wiki] ;
中文:
TMC-310911 [Wiki] ;
German:
(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl-{(2S,3R)-4-[({2-[(1-cyclopentyl-4-piperidinyl)amino]-1,3-benzothiazol-6-yl}sulfonyl)(isobutyl)amino]-3-hydroxy-1-phenyl-2-butanyl}carbamat (IUPAC) ;
French:
{(2S,3R)-4-[({2-[(1-Cyclopentyl-4-pipéridinyl)amino]-1,3-benzothiazol-6-yl}sulfonyl)(isobutyl)amino]-3-hydroxy-1-phényl-2-butanyl}carbamate de (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yle (IUPAC) ;
Molecular formula:
C5H4N6O3S
CAS# 123606-06-4
Names
English:
7-(Methylsulfanyl)-3-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-4(6H)-one (IUPAC) ; Riamilovir ; TZV ; Triazavirin [Wiki] ; [1,2,4]Triazolo[5,1-c][1,2,4]triazin-4(6H)-one, 7-(methylthio)-3-nitro- (CAS) ;
German:
7-(Methylsulfanyl)-3-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-4(6H)-on (IUPAC) ;
French:
7-(Méthylsulfanyl)-3-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-4(6H)-one (IUPAC) ; riamilovir ;
Español:
riamilovir ;
Latina:
riamilovirum ;
العربية:
رياميلوفير ;
Italiano:
Triazavirin [Wiki] ;
Русский:
Риамиловир [Wiki] ;
Molecular formula:
C5H7N6NaO5S
CAS# 928659-17-0
Names
English:
EX-A3433 ; Riamilovir Sodium Dihydrate ; Sodium 7-(methylsulfanyl)-3-nitro-4-oxo-4H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-1-ide hydrate (1:1:2) (IUPAC) ; Triazavirin [Wiki] ; [1,2,4]Triazolo[5,1-c][1,2,4]triazin-4(1H)-one, 7-(methylthio)-3-nitro-, sodium salt, hydrate (1:1:2) (CAS) ; sodium;7-methylsulfanyl-3-nitro-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-olate;dihydrate (IUPAC) ;
Русский:
Метилтионитрооксодигидротриазолотриазинид натрия [Wiki] ; Риамиловир натрия дигидрат ; Триазавирин ;
French:
7-(Méthylsulfanyl)-3-nitro-4-oxo-4H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-1-ide de sodium, hydrate (1:1:2) (IUPAC) ;
Molecular formula:
C33H38O11
CAS# 111514-63-7
Names
English:
(2R,4R,5S,6R,7S,8R,9R,12R)-5,12-Diacetoxy-2,4-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.01,6 ]dodecane-7,8-diyl dibenzoate (IUPAC) ; 2H-3,9a-Methano-1-benzoxepin-4,5,6,7,9,10-hexol, octahydro-2,2,5a,9-tetramethyl-, 6,10-diacetate 4,5-dibenzoate, (3R,4R,5S,5aR,6S,7R,9R,10R)- (CAS) ; Triptofordin C-2 [Wiki] ;
Русский:
Триптофордин C-2 ;
Molecular formula:
C22H29ClN3O9P
CAS# 1496551-77-9
Names
English:
IDX-21437 ; Isopropyl (2R)-2-{[(R)-{[(2R,3R,4R,5R)-4-chloro-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-3-hydroxy-4-methyltetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name) (IUPAC) ; MK-3682 ; Uprifosbuvir [Wiki] ; Uridine, 2'-chloro-2'-deoxy-2'-methyl-5'-O-[(R)-[[(1R)-1-methyl-2-(1-methylethoxy)-2-oxoethyl]amino]phenoxyphosphinyl]- (CAS) ;
中文:
Uprifosbuvir [Wiki] ; 乌磷布韦 ;
French:
(2R)-2-{[(R)-{[(2R,3R,4R,5R)-4-Chloro-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-3-hydroxy-4-méthyltétrahydro-2-furanyl]méthoxy}(phénoxy)phosphoryl]amino}propanoate d'isopropyle (non-preferred name) (IUPAC) ; uprifosbuvir ;
German:
Isopropyl-(2R)-2-{[(R)-{[(2R,3R,4R,5R)-4-chlor-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-3-hydroxy-4-methyltetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoat (non-preferred name) (IUPAC) ;
Español:
uprifosbuvir ;
Latina:
uprifosbuvirum ;
Русский:
уприфосбувир ;
العربية:
أوبريفوسبوفير ;
Molecular formula:
C15H24N4O6
CAS# 640281-90-9
Names
English:
2'-C-Methyl-3'-O-L-valylcytidine (IUPAC) ; Cytidine, 3'-O-[(2S)-2-amino-3-methyl-1-oxobutyl]-2'-C-methyl- (CAS) ; NM-283 ; NMC-283 ; Valopicitabine [Wiki] ;
Русский:
[(2R,3R,4R,5R)-5-(4-амино-2-оксопиримидин-1-ил)-4-гидрокси-2-(гидроксиметил)-4-метилоксолан-3-ил] (2S)-2-амино-3-метилбутаноат ; Валопицитабин [Wiki] ;
German:
2'-C-Methyl-3'-O-L-valylcytidin (IUPAC) ;
French:
2'-C-Méthyl-3'-O-L-valylcytidine (IUPAC) ; valopicitabine ;
Español:
valopicitabina ;
Latina:
valopicitabinum ;
العربية:
فالوبيسيتابين ;
中文:
伐洛他滨 ;
Molecular formula:
C25H38O2
CAS# 253664-30-1
Names
English:
(1S,3R,6S,9S,10S,11S,13E,17R,19S,20R)-3,6,19-trimethyl-9-prop-1-en-2-yl-16-oxapentacyclo[12.5.1.03,11 .06,10 .017,20 ]icos-13-en-17-ol (IUPAC) ; Valiecolol ; Variecolol [Wiki] ;
Русский:
Вариеколол ;
Molecular formula:
C22H30N6O2
CAS# 1228585-88-3
Names
English:
4-Amino-2-butoxy-8-[3-(1-pyrrolidinylmethyl)benzyl]-7,8-dihydro-6(5H)-pteridinone (IUPAC) ; 6(5H)-Pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]- (CAS) ; GS-9620 ; Vesatolimod [Wiki] ;
German:
4-Amino-2-butoxy-8-[3-(1-pyrrolidinylmethyl)benzyl]-7,8-dihydro-6(5H)-pteridinon (IUPAC) ;
French:
4-Amino-2-butoxy-8-[3-(1-pyrrolidinylméthyl)benzyl]-7,8-dihydro-6(5H)-ptéridinone (IUPAC) ; vésatolimod ;
Español:
vesatolimod ;
Latina:
vesatolimodum ;
Русский:
Весатолимод ;
العربية:
فيساتوليمود ;
中文:
维托莫德 ;
Molecular formula:
C22H25N5O3S
CAS# 1422500-60-4
Names
English:
4-Quinazolinamine, N-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5H)-yl)-6-methyl- (CAS) ; N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine (IUPAC) ; N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-2H-1λ6 ,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine (IUPAC) ; Ziresovir [Wiki] ;
中文:
齐瑞索韦 ; 齐雷索韦 [Wiki] ;
German:
N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-chinazolinamin (IUPAC) ;
French:
N-[(3-Amino-3-oxétanyl)méthyl]-2-(1,1-dioxydo-2,3-dihydro-1,4-benzothiazépin-4(5H)-yl)-6-méthyl-4-quinazolinamine (IUPAC) ;
Русский:
зиресовир ;
العربية:
زيريسوفير ;
Molecular formula:
C31H33F3N2O5S
CAS# 174484-41-4
Names
English:
2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)- (CAS) ; Aptivus ; N-(3-{(1R)-1-[(6R)-4-Hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)-2-pyridinesulfonamide (IUPAC) ; Tipranavir [Wiki] ; U-140690 ;
Русский:
Типранавир [Wiki] ;
العربية:
تيبرانافير [Wiki] ;
German:
N-(3-{(1R)-1-[(6R)-4-Hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluormethyl)-2-pyridinsulfonamid (IUPAC) ; N-[3-[(1R)-1-[(2R)-6-Hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridin-2-sulfonamid ; Tipranavir [Wiki] ;
Español:
Tipranavir [Wiki] ;
Italiano:
Tipranavir [Wiki] ; propil-3H-piran-5-il]propil]fenil]-5-(trifluorometil)piridina-2-sulfonammide ;
French:
N-(3-{(1R)-1-[(6R)-4-Hydroxy-2-oxo-6-(2-phényléthyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phényl)-5-(trifluorométhyl)-2-pyridinesulfonamide (IUPAC) ; tipranavir ;
Latina:
tipranavirum ;
中文:
替拉那韦 ;
Molecular formula:
C14H15IN2O
CAS# 201349-37-3
Names
English:
4-(Benzylcarbamoyl)-1-methylpyridinium iodide (IUPAC) ; Enisamium iodide [Wiki] ; MLS001211478 ; Pyridinium, 1-methyl-4-[[(phenylmethyl)amino]carbonyl]-, iodide (1:1) (CAS) ;
Русский:
4-(N-бензил)аминокарбонил-1-метилпиридиний йодид ; N-метил-4-бензилкарбамидопиридиния йодид ; Амизон® ; Амизон® Макс ; Амизончик® ; Энисамиума йодид [Wiki] ; карбабензпирид ;
German:
4-(Benzylcarbamoyl)-1-methylpyridiniumiodid (IUPAC) ;
Latina:
enisamii iodidum ;
French:
Iodure de 4-(benzylcarbamoyl)-1-méthylpyridinium (IUPAC) ; iodure d'énisamium ;
Español:
ioduro de enisamio ;
العربية:
إينيساميوم إيوديد ;
中文:
依尼碘铵 ;
Molecular formula:
C32H45N3O4S
CAS# 159989-64-7
Names
English:
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboxamide (IUPAC) ; (3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-{(E)-[hydroxy(3-hydroxy-2-methylphenyl)methylene]amino}-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboximidic acid (IUPAC) ; (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide ; (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide ; 159989-64-7 ; 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)- (CAS) ; 3-Isoquinolinecarboximidic acid, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[[(1E)-hydroxy(3-hydroxy-2-methylphenyl)methylene]amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)- (CAS) ; AG-1343 ; HO3OGH5D7I ; MFCD01938163 ; Nelfinavir [Wiki] ; Nelfinavir (INN) ; SMR000596515 ; Viracept ; Viracept (TN) ;
العربية:
نيلفينافير [Wiki] ;
Español:
Nelfinavir [Wiki] ;
French:
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-méthylbenzoyl)amino]-4-(phénylsulfanyl)butyl]-N-(2-méthyl-2-propanyl)décahydro-3-isoquinoléinecarboxamide (IUPAC) ; Acide (3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-{(E)-[hydroxy(3-hydroxy-2-méthylphényl)méthylène]amino}-4-(phénylsulfanyl)butyl]-N-(2-méthyl-2-propanyl)décahydro-3-isoquinoléinecarboximidique (IUPAC) ; Nelfinavir [Wiki] ;
Italiano:
Nelfinavir [Wiki] ;
日本語:
ネルフィナビル [Wiki] ;
Русский:
Нельфинавир [Wiki] ;
中文:
奈非那韦 [Wiki] ;
German:
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isochinolincarboxamid (IUPAC) ; (3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-{(E)-[hydroxy(3-hydroxy-2-methylphenyl)methylen]amino}-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isochinolincarboximidsäure (IUPAC) ; Nelfinavir [Wiki] ;
Latina:
nelfinavirum ;